NYSE:TMO - Thermo Fisher Scientific Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$230.14 +0.14 (+0.06 %)
(As of 08/20/2018 04:00 PM ET)
Previous Close$230.00
Today's Range$229.90 - $230.94
52-Week Range$172.51 - $236.29
Volume819,900 shs
Average Volume1.43 million shs
Market Capitalization$93.22 billion
P/E Ratio24.29
Dividend Yield0.29%
Beta1.13
Thermo Fisher Scientific logoThermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNYSE:TMO
CUSIP88355610
Phone781-622-1000

Debt

Debt-to-Equity Ratio0.67
Current Ratio1.58
Quick Ratio1.11

Price-To-Earnings

Trailing P/E Ratio24.29
Forward P/E Ratio20.96
P/E Growth1.69

Sales & Book Value

Annual Sales$20.92 billion
Price / Sales4.43
Cash Flow$14.4018 per share
Price / Cash15.98
Book Value$63.38 per share
Price / Book3.63

Profitability

EPS (Most Recent Fiscal Year)$9.49
Net Income$2.23 billion
Net Margins10.36%
Return on Equity16.28%
Return on Assets7.44%

Miscellaneous

Employees70,000
Outstanding Shares402,800,000
Market Cap$93.22 billion

Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Friday, July 13th. Stockholders of record on Monday, September 17th will be paid a dividend of $0.17 per share on Monday, October 15th. This represents a $0.68 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, September 14th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) released its quarterly earnings data on Wednesday, July, 25th. The medical research company reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. The medical research company earned $6.08 billion during the quarter, compared to the consensus estimate of $5.90 billion. Thermo Fisher Scientific had a net margin of 10.36% and a return on equity of 16.28%. The company's revenue for the quarter was up 21.8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.30 EPS. View Thermo Fisher Scientific's Earnings History.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Thermo Fisher Scientific.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific updated its FY18 earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of $10.89-11.01 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.90. The company issued revenue guidance of $23.68-23.86 billion, compared to the consensus revenue estimate of $23.78 billion.

What price target have analysts set for TMO?

12 brokerages have issued 12-month price targets for Thermo Fisher Scientific's stock. Their predictions range from $195.00 to $300.00. On average, they anticipate Thermo Fisher Scientific's share price to reach $237.0909 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price. View Analyst Price Targets for Thermo Fisher Scientific.

What is the consensus analysts' recommendation for Thermo Fisher Scientific?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 1 hold rating and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Thermo Fisher Scientific.

Are investors shorting Thermo Fisher Scientific?

Thermo Fisher Scientific saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 3,769,071 shares, an increase of 47.0% from the July 13th total of 2,564,556 shares. Based on an average trading volume of 1,994,647 shares, the short-interest ratio is presently 1.9 days. Currently, 0.9% of the company's shares are short sold. View Thermo Fisher Scientific's Current Options Chain.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 50)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 51)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 55)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 52)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 51)

Has Thermo Fisher Scientific been receiving favorable news coverage?

News headlines about TMO stock have trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Thermo Fisher Scientific earned a coverage optimism score of 0.19 on Accern's scale. They also assigned media coverage about the medical research company an impact score of 47.52 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Thermo Fisher Scientific.

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (5.51%), FMR LLC (1.36%), Morgan Stanley (1.09%), Bank of New York Mellon Corp (0.82%), Veritas Asset Management LLP (0.80%) and Longview Partners Guernsey LTD (0.80%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Which institutional investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, FMR LLC, Point72 Asset Management L.P., Glenmede Trust Co. NA, Veritas Asset Management LLP, Russell Investments Group Ltd., Longview Partners Guernsey LTD and Winslow Capital Management LLC. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include C Martin Harris, Daniel P Shine, Gregory J Herrema, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Seth H Hoogasian, Stephen Williamson and William G Parrett. View Insider Buying and Selling for Thermo Fisher Scientific.

Which institutional investors are buying Thermo Fisher Scientific stock?

TMO stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Chevy Chase Trust Holdings Inc., Gofen & Glossberg LLC IL, Voya Investment Management LLC, Natixis, Orbimed Advisors LLC, Ferguson Wellman Capital Management Inc. and Caledonia Investments PLC. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $230.14.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $93.22 billion and generates $20.92 billion in revenue each year. The medical research company earns $2.23 billion in net income (profit) each year or $9.49 on an earnings per share basis. Thermo Fisher Scientific employs 70,000 workers across the globe.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]


MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  586 (Vote Outperform)
Underperform Votes:  271 (Vote Underperform)
Total Votes:  857
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe TMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Featured Article: Leveraged Buyout (LBO)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel